MTNB
Matinas Biopharma Holdings, Inc.
$0.61+0.00 (0.00%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Matinas BioPharma Holdings, Inc. (MTNB) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
5 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-05-02 | 2025-04-30 | D An Evelyn | Director | Award | 11,600 | $0.00 | $0 | N/A | N/A |
| 2025-05-02 | 2025-04-30 | Murphy Keith | Director | Award | 11,600 | $0.00 | $0 | N/A | N/A |
| 2025-05-02 | 2025-04-30 | Jabbour Jerome D | CEO | Award | 70,100 | $0.00 | $0 | N/A | N/A |
| 2025-05-02 | 2025-04-30 | Neugeboren Edward | Director | Award | 11,600 | $0.00 | $0 | N/A | N/A |
| 2025-05-02 | 2025-04-30 | Smith Robin L | Director | Award | 11,600 | $0.00 | $0 | N/A | N/A |